Research published this week suggests a specific fungus is present in Clostridium difficile infections, potentially presenting a future therapeutic target.
Stainless steel and surgical gowns remain contaminated with Clostridium difficile even after treatment with the recommended disinfectant, according to new research.
In a new review of the condition, experts from NIAID have called for a galvanized research response to growing cases of acute flaccid myelitis.
Microbiome metabolites have been discovered to enhance colon injury in human EHEC infections in a human–mouse comparative study, accounting for species-specific differences in infection tolerance.
New research has identified a link between the use of non-steroidal anti-inflammatory drugs – commonly used as pain relief – and more severe C. difficile infections in mouse models.
Concurrent major US and Canadian clinical trials prove probiotics to be ineffective in combatting gastroenteritis in children.
Scientists exploring the genome of Salmonella enterica Serovar Typhi have unveiled the alarming presence of antimicrobial resistance genes from isolates of the recent outbreak in Bangladesh; new geographical origins and spread of resistance is implicated.
Glenn Tillotson gives us an overview of the CDiff Foundation’s 6th annual educational meeting, including updates on new C. difficile IDSA/SHEA clinical guidelines and patient perspectives.
Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.
In this interview, we spoke to Yoav Golan about recent developments in the field of Clostridium difficile infections – from the latest clinical trial results to newly updated guidelines.
